Search

everythinglearnresearchcommunity

for

Search:↓

Tanshinone IIA helps protect tissue from low oxygen damage by activating certain cell pathways.

Low-penetration genes might help personalize colorectal cancer prevention.

Most patients with alopecia areata see significant hair regrowth within 93 days of starting ritlecitinib treatment.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Blocking a key energy pathway in human hair follicles can trigger stress responses that stop cell growth.

Antituberculosis drugs can cause severe skin reactions, requiring careful diagnosis and treatment.

Microbeam Radiation Therapy is effective, but using a linear accelerator reduces its benefits.

VEGF and VEGFR-2 genes influence feather maturity, and specific genetic markers can improve chicken breeding.

Acitretin effectively prevented skin cancer in a patient with late-onset Rothmund-Thomson syndrome.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

The research helps understand how finasteride works and aids drug development.

mTORC1 signaling needed for quick hair follicle recovery after radiation damage.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

Mutations in the TSPEAR gene cause a new form of ectodermal dysplasia affecting hair and tooth development.

High mTORC1 activity slows hair growth and causes it to lose color.

A young patient with unusual insulin resistance and high testosterone levels had a rare INSR gene mutation.

Skin tumor cells in patients with tuberous sclerosis have higher levels of a protein called cathepsin B.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

Retinoic acid can either maintain stem cells or make them specialize, depending on the cell type.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

The three estrogen receptor genes are highly expressed in zebrafish neuromasts during development.

Cox-2 significantly contributes to the development and progression of skin and esophageal cancers.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

The PTGER2 gene is highly active in Cashmere goat skin and its activity changes with the hair growth cycle.

Low-level laser therapy may help uninfected cells but has different effects on coronavirus-infected cells.

A new genetic mutation in the TRPV3 gene causes Olmsted-like syndrome in a Mongolian family.